Zydus Lifesciences Ltd
NSE :ZYDUSLIFE BSE :532321 Sector : PharmaceuticalsBuy, Sell or Hold ZYDUSLIFE? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
20 Mar 917.25 (0.81%) | 19 Mar 909.90 (0.86%) | 18 Mar 902.15 (1.06%) | 17 Mar 892.70 (1.09%) | 13 Mar 883.10 (-0.58%) | 12 Mar 888.25 (-1.29%) | 11 Mar 899.85 (0.69%) | 10 Mar 893.70 (-0.79%) | 07 Mar 900.80 (-0.73%) | 06 Mar 907.40 (2.25%) | 05 Mar 887.45 (1.81%) | 04 Mar 871.65 (0.14%) | 03 Mar 870.45 (-0.70%) | 28 Feb 876.60 (-1.11%) | 27 Feb 886.45 (0.40%) | 25 Feb 882.95 (-0.93%) | 24 Feb 891.25 (0.67%) | 21 Feb 885.35 (-1.59%) | 20 Feb 899.65 (0.92%) | 19 Feb 891.45 (-2.47%) | 18 Feb 914.05 (-1.07%) |
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Bearish
Long Term Investors

Very Bearish
Moving Averages
5 DMA
Bullish
901.06
10 DMA
Bullish
899.55
20 DMA
Bullish
891.91
50 DMA
Bearish
936
100 DMA
Bearish
955.15
200 DMA
Bearish
1036.32
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Mar 20, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 941.41 | 932.88 | 921.75 | - | - |
R2 | 932.88 | 926.63 | 920.25 | 933.06 | - |
R1 | 925.06 | 922.78 | 918.75 | 925.42 | 928.98 |
P | 916.53 | 916.53 | 916.53 | 916.71 | 918.49 |
S1 | 908.71 | 910.28 | 915.75 | 909.07 | 912.63 |
S2 | 900.18 | 906.43 | 914.25 | 900.36 | - |
S3 | 892.36 | 900.18 | 912.75 | - | - |
Key Metrics
EPS
43.46
P/E
21.09
P/B
5.15
Dividend Yield
0.33%
Market Cap
92,297 Cr.
Face Value
1
Book Value
177.87
ROE
20.64%
EBITDA Growth
1,443.8 Cr.
Debt/Equity
0.05
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Zydus Lifesciences Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 4564.7 | 5693.4 | 6270.7 | 5305.5 | 5326.6 | |
PROFIT | 767.8 | 1179.1 | 1419.9 | 910.9 | 1023.8 | |
EPS | 7.8 | 11.69 | 14.11 | 9.06 | 10.17 |
Zydus Lifesciences Ltd Quaterly Results
Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | ||
INCOME | 2478.1 | 3693.5 | 4266.8 | 2947.3 | 2593.4 | |
PROFIT | 450.4 | 1411.72 | 1700.8 | 789.8 | 470.6 | |
EPS | 4.45 | 13.89 | 16.9 | 7.85 | 4.68 |
Profit & Loss (Figures in Rs. Crores)
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 8804.1 | 9553.5 | 9643.7 | 12333.5 | 13476.4 | 14460.8 | 14605.3 | 18055.3 | 17185.9 | 20108.2 | |
PROFIT | 1157.11 | 1936.48 | 1488.67 | 1743.64 | 1793 | 1473.53 | 2369.75 | 4387.47 | 2387.89 | 3860.05 | |
EPS | 10.9 | 18.76 | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 | 38.31 |
Zydus Lifesciences Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 5545.6 | 7156.7 | 3960.8 | 6204.7 | 6728.6 | 7240.6 | 8017.6 | 8062.5 | 9174.9 | 12035.2 | |
PROFIT | 1270.15 | 2038.39 | 662.54 | 1056.56 | 1411.26 | 1465.57 | 1633.15 | 1095.54 | 1621.47 | 3437.6 | |
EPS | 11.97 | 19.9 | 6.45 | 10.65 | 14.51 | 13.8 | 14.42 | 8.38 | 15.11 | 34.21 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 19,728.9 | 17,414.6 | 16,897.2 | 12,889.9 | 10,273.3 | 10,283.9 | 8,642.1 | 6,857.6 | 5,596.8 | 4,149.2 |
Total Shareholders Funds | 19,829.5 | 17,515.8 | 16,999.6 | 12,992.3 | 10,375.7 | 10,386.3 | 8,744.5 | 6,960 | 5,699.2 | 4,251.6 |
Minority Interest | 2,272.1 | 2,172.5 | 2,054.2 | 1,937.3 | 1,334.7 | 1,292.9 | 191 | 156.1 | 135.8 | 168.9 |
Secured Loans | 0 | 0 | 500 | 383.9 | 1,873.2 | 2,585.7 | 481.2 | 1,197 | 689.8 | 1,169.1 |
Unsecured Loans | 804.2 | 1,194.9 | 3,720.9 | 4,223.7 | 6,113.2 | 5,313.7 | 4,925.5 | 4,010.2 | 1,752.2 | 1,482.2 |
Total Debt | 804.2 | 1,194.9 | 4,220.9 | 4,607.6 | 7,986.4 | 7,899.4 | 5,406.7 | 5,207.2 | 2,442 | 2,651.3 |
Other Liabilities | 1,367.9 | 327.2 | 382.8 | 349.5 | 282.3 | 259.4 | 209.6 | 214 | 157.3 | 132.5 |
Total Liabilities | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 19,919.8 | 18,343.8 | 17,650.9 | 17,345 | 16,781.5 | 15,702.3 | 9,349.1 | 8,102.9 | 5,767.3 | 5,138.5 |
Less: Accumulated Depreciation | 7,551.3 | 6,822.9 | 5,462.4 | 5,212.2 | 4,551 | 3,538.6 | 2,866.5 | 2,347.8 | 2,019.4 | 1,786.3 |
Net Block | 12,368.5 | 11,520.9 | 12,188.5 | 12,132.8 | 12,230.5 | 12,163.7 | 6,482.6 | 5,755.1 | 3,747.9 | 3,352.2 |
Capital Work in Progress | 2,423.3 | 1,200.7 | 725.9 | 783.2 | 741.5 | 837.2 | 1,527.2 | 1,543.3 | 950.8 | 797.9 |
Investments | 1,220.5 | 1,546.6 | 3,288 | 830.1 | 765 | 673.5 | 745.7 | 434.8 | 416.2 | 154.4 |
Inventories | 3,441.9 | 3,413.3 | 3,719.4 | 3,236.2 | 2,789 | 2,688 | 2,385.3 | 1,803.7 | 1,337.1 | 1,535.7 |
Sundry Debtors | 5,220.2 | 4,416.8 | 3,340.3 | 3,127.3 | 3,663.2 | 3,950.8 | 3,206.3 | 2,277.5 | 1,746.6 | 1,588.4 |
Cash and Bank Balance | 1,105.1 | 573.1 | 1,106.9 | 888.3 | 964.9 | 548.9 | 1,314.9 | 1,543.5 | 638.7 | 669.9 |
Loans and Advances | 1,400.1 | 985.7 | 1,575.4 | 1,265.3 | 1,085.5 | 1,080.5 | 1,048.4 | 348.5 | 358.9 | 311.5 |
Total Current Assets | 11,167.3 | 9,388.9 | 9,742 | 8,517.1 | 8,502.6 | 8,268.2 | 7,954.9 | 5,973.2 | 4,081.3 | 4,105.5 |
Current Liabilities | 3,793.8 | 3,829.4 | 3,576.7 | 3,460 | 3,225.3 | 3,203.4 | 3,079.2 | 2,498.1 | 1,834.1 | 1,398.8 |
Provisions | 766.8 | 522.2 | 407.4 | 418.3 | 272.3 | 189.4 | 152.2 | 68.9 | 81.3 | 382.5 |
Total Current Liabilities & Provisions | 4,560.6 | 4,351.6 | 3,984.1 | 3,878.3 | 3,497.6 | 3,392.8 | 3,231.4 | 2,567 | 1,915.4 | 1,784.2 |
Net Current Assets | 6,606.7 | 5,037.3 | 5,757.9 | 4,638.8 | 5,005 | 4,875.4 | 4,723.5 | 3,406.2 | 2,165.9 | 2,321.3 |
Deferred Tax Assets | 4,261.9 | 3,121.4 | 1,330.9 | 2,820.1 | 1,316.3 | 1,775.7 | 2,374.1 | 2,325.6 | 518.5 | 182.9 |
Deferred Tax Liability | 3,064.2 | 2,053.4 | 388.9 | 1,865.4 | 673.3 | 1,057.7 | 1,731.6 | 1,546.5 | 200.9 | 241.5 |
Net Deferred Tax | 1,197.7 | 1,068 | 942 | 954.7 | 643 | 718 | 642.5 | 779.1 | 317.6 | -58.6 |
Other Assets | 457 | 836.9 | 755.2 | 547.1 | 594.1 | 570.2 | 430.3 | 618.8 | 835.9 | 637.1 |
Total Assets | 24,273.7 | 21,210.4 | 23,657.5 | 19,886.7 | 19,979.1 | 19,838 | 14,551.8 | 12,537.3 | 8,434.3 | 7,204.3 |
Contingent Liabilities | 753.2 | 801.1 | 666.7 | 668 | 673.8 | 459.9 | 291.5 | 199 | 234.1 | 163.7 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 100.6 | 101.2 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 | 102.4 |
Reserves Total | 15,615.9 | 13,538.2 | 13,138.1 | 12,642.1 | 11,157.8 | 8,466.8 | 7,643.1 | 6,515.9 | 6,173.8 | 4,423 |
Total Shareholders Funds | 15,716.5 | 13,639.4 | 13,240.5 | 12,744.5 | 11,260.2 | 8,569.2 | 7,745.5 | 6,618.3 | 6,276.2 | 4,525.4 |
Secured Loans | 0 | 0 | 500 | 383.9 | 356.9 | 319.4 | 246.8 | 961.4 | 453.7 | 922.9 |
Unsecured Loans | 6,178.3 | 4,825.3 | 2,164.7 | 3,536 | 3,337.8 | 3,263.9 | 2,625.7 | 1,978.4 | 769.1 | 526.8 |
Total Debt | 6,178.3 | 4,825.3 | 2,664.7 | 3,919.9 | 3,694.7 | 3,583.3 | 2,872.5 | 2,939.8 | 1,222.8 | 1,449.7 |
Other Liabilities | 209.7 | 166.2 | 191.3 | 179.2 | 132.7 | 114.5 | 82.8 | 70.3 | 110.4 | 84.4 |
Total Liabilities | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 8,677.4 | 7,999.8 | 7,675.6 | 7,009.1 | 6,564.2 | 6,152.3 | 4,515.7 | 3,896.3 | 3,720.5 | 3,118.9 |
Less : Accumulated Depreciation | 4,308 | 3,815.7 | 3,339.7 | 2,897.1 | 2,455.2 | 2,219.8 | 1,835.5 | 1,544.3 | 1,565.7 | 1,350.8 |
Net Block | 4,369.4 | 4,184.1 | 4,335.9 | 4,112 | 4,109 | 3,932.5 | 2,680.2 | 2,352 | 2,154.8 | 1,768.1 |
Capital Work in Progress | 633.9 | 739.3 | 384 | 570.5 | 552.6 | 674.9 | 659.2 | 678.4 | 296.8 | 366.9 |
Investments | 7,283 | 4,879.3 | 5,118 | 6,470.6 | 6,404.1 | 4,195.2 | 3,618.1 | 3,923.7 | 2,317.5 | 2,209.1 |
Inventories | 1,687.3 | 1,782.4 | 1,926.3 | 1,780 | 1,394.7 | 1,472.5 | 1,320.7 | 932.9 | 657.5 | 804.3 |
Sundry Debtors | 4,740.1 | 3,505.3 | 2,277.7 | 1,903.8 | 2,456.7 | 2,112.1 | 1,255.1 | 929 | 1,707.3 | 1,056.1 |
Cash and Bank Balance | 414.4 | 248.1 | 302.6 | 154 | 385.3 | 112.1 | 183.8 | 16.8 | 163.7 | 129.4 |
Loans and Advances | 1,069.5 | 1,420.8 | 2,110.3 | 2,193.9 | 556 | 560.6 | 797.8 | 260.7 | 293.9 | 249.2 |
Total Current Assets | 7,911.3 | 6,956.6 | 6,616.9 | 6,031.7 | 4,792.7 | 4,257.3 | 3,557.4 | 2,139.4 | 2,822.4 | 2,239 |
Current Liabilities | 1,669.2 | 1,539.3 | 1,384.5 | 1,401.7 | 1,195.1 | 1,157.9 | 1,217.3 | 1,283.7 | 1,074.3 | 814.8 |
Provisions | 252.8 | 199.1 | 105.9 | 111 | 70.5 | 89.6 | 52 | 29.8 | 54.9 | 339.5 |
Total Current Liabilities & Provisions | 1,922 | 1,738.4 | 1,490.4 | 1,512.7 | 1,265.6 | 1,247.5 | 1,269.3 | 1,313.5 | 1,129.2 | 1,154.3 |
Net Current Assets | 5,989.3 | 5,218.2 | 5,126.5 | 4,519 | 3,527.1 | 3,009.8 | 2,288.1 | 825.9 | 1,693.2 | 1,084.7 |
Deferred Tax Assets | 179.9 | 112 | 136.6 | 129.7 | 92.2 | 123.9 | 67 | 143.6 | 0 | 81.6 |
Deferred Tax Liability | 238.2 | 306.3 | 289.7 | 237 | 290.5 | 280.5 | 260.6 | 249.1 | 184.6 | 205.2 |
Net Deferred Tax | -58.3 | -194.3 | -153.1 | -107.3 | -198.3 | -156.6 | -193.6 | -105.5 | -184.6 | -123.6 |
Other Assets | 3,887.2 | 3,804.3 | 1,285.2 | 1,278.8 | 693.1 | 611.2 | 1,648.8 | 1,953.9 | 1,331.7 | 754.3 |
Total Assets | 22,104.5 | 18,630.9 | 16,096.5 | 16,843.6 | 15,087.6 | 12,267 | 10,700.8 | 9,628.4 | 7,609.4 | 6,059.5 |
Contingent Liabilities | 111 | 319.9 | 1,797.1 | 1,503.9 | 3,690.3 | 3,100.3 | 2,563.3 | 2,292 | 1,417.2 | 1,296 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 4,838.1 |
Depreciation | 764.1 |
Interest (Net) | -51.2 |
Dividend Received | 1.3 |
P/L on Sales of Assets | -13.4 |
Prov. and W/O (Net) | 61.1 |
P/L in Forex | -88.3 |
Others | -725 |
Total Adjustments (PBT and Ext... | 546.7 |
Operating Profit before Workin... | 5,384.8 |
Trade and 0ther Receivables | -747.2 |
Inventories | -2 |
Trade Payables | -44.8 |
Total Adjustments (OP before W... | -871.1 |
Cash Generated from/(used in) ... | 4,513.7 |
Direct Taxes Paid | -1,285.8 |
Total Adjustments(Cash Generat... | -1,285.8 |
Cash Flow before Extraordinary... | 3,227.9 |
Net Cash from Operating Activi... | 3,227.9 |
Purchased of Fixed Assets | -906.6 |
Sale of Fixed Assets | 23.7 |
Purchase of Investments | -106.7 |
Sale of Investments | 407.7 |
Interest Received | 127.4 |
Cancellation of Investment in ... | 55 |
Net Cash used in Investing Act... | -1,492.3 |
Proceed from 0ther Long Term B... | 1.4 |
Of the Long Tem Borrowings | -82.7 |
Of the Short Term Borrowings | -310.2 |
Dividend Paid | -621 |
Interest Paid | -72.9 |
Net Cash used in Financing Act... | -1,810.4 |
Net Profit before Tax and Extr... | 4,239.8 |
Depreciation | 504.4 |
Interest (Net) | 66.1 |
Dividend Received | 602.3 |
P/L on Sales of Assets | -13.6 |
Prov. and W/O (Net) | 49.2 |
P/L in Forex | -56.6 |
Others | -725 |
Total Adjustments (PBT and Ext... | -156 |
Operating Profit before Workin... | 4,083.8 |
Trade and 0ther Receivables | -1,255.1 |
Inventories | 95.1 |
Trade Payables | 90.9 |
Total Adjustments (OP before W... | -1,187 |
Cash Generated from/(used in) ... | 2,896.8 |
Direct Taxes Paid | -897.7 |
Total Adjustments(Cash Generat... | -897.7 |
Cash Flow before Extraordinary... | 1,999.1 |
Net Cash from Operating Activi... | 1,999.1 |
Purchased of Fixed Assets | -584.2 |
Sale of Fixed Assets | 18.8 |
Sale of Investments | 215.8 |
Interest Received | 295.1 |
Invest.In Subsidiaires | -2,670.7 |
Loans to Subsidiaires | -82.8 |
Cancellation of Investment in ... | 18.2 |
Net Cash used in Investing Act... | -1,830.6 |
Proceed from 0ther Long Term B... | 2,063.9 |
Of the Long Tem Borrowings | -360.8 |
Of the Short Term Borrowings | -352.3 |
Dividend Paid | -607.5 |
Interest Paid | -319.1 |
Net Cash used in Financing Act... | -300.8 |
Company Details
Registered Office |
|
Address | Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Registrars |
|
Address | Zydus Corporate Park S No 536 |
City | Ahmedabad |
State | Gujarat |
Pin Code | 382481 |
Tel. No. | 91-079-26868100 |
Fax. No. | 91-079-26868337/26862365/26862366 |
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila. | |
Internet | http://www.zyduscadila.com |
Management |
|
Name | Designation |
Pankaj R Patel | Chairman (Non-Executive) |
Sharvil P Patel | Managing Director |
Mukesh M Patel | Non Executive Director |
Apurva S Diwanji | Independent Director |
Ganesh N Nayak | Whole-time Director |
Bhadresh K Shah | Independent Director |
Dhaval N Soni | Company Sec. & Compli. Officer |
Akhil A. Monappa | Independent Director |
Upasana Konidela. | Independent Director |
Shelina P. Parikh | Independent Director |